| Registry | NCT06752278 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 40 (Actual) |
| Sponsor | Al-Azhar University (Other) |
| Conditions | Dry Eye Disease (DED) |
| Interventions | Pilocarpine, artificial tears (Drug) |
| Dates | start 2024-10-01, primary completion 2024-12-01, completion 2024-12-20, first posted 2024-12-30, last updated 2024-12-30 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Dry Eye Disease (DED) All trials of Pilocarpine All trials of artificial tears
Management approaches for dry eye disease (DED) typically start with low-risk, easily accessible, patient-applied therapies like artificial tears for early-stage disease. As the condition worsens, treatment progresses to more advanced therapies for severe forms of DED. This study aims to compare the effectiveness and safety of pilocarpine as a secretagogue versus artificial tears in the treatment of dry eye disease. Our goal is to provide reliable, high-quality evidence regarding the efficacy of secretagogues, thereby contributing to the development of recommendations that aid clinicians in their decision-making process
| Arm | Type | Interventions | Description |
|---|---|---|---|
| pilocarpine group | Active comparator | Drug: Pilocarpine | |
| artificial tears group | Active comparator | Drug: artificial tears |
Sex: All
Inclusion Criteria: * Patients diagnosed with DED Exclusion Criteria: * Previous Occular surgery. * Refuse to particupate. * Patients with sjogren syndrome
| Facility | City | Country | Status |
|---|---|---|---|
| Al-Azhar university | Damietta | Egypt |